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Thesis Synopsis 
 
The current, grim world-TB scenario, with TB being the single largest infectious disease 
killer, warrants a more effective approach to tackle the deadly pathogen, Mycobacterium 
tuberculosis. The deadly synergy of this pathogen with HIV and the emergence of drug-
resistant strains of the organism present a challenge for disease treatment (Russell et al., 
2010). Thus, there is a pressing need for newer drugs with faster killing-kinetics which can 
claim both the actively-multiplying and latent forms of this pathogen causing the oldest 
known disease to man. This thesis entitled “Mechanistic and Regulatory Aspects of the 
Mycobacterium tuberculosis Dephosphocoenzyme A Kinase” describes one such potential 
drug target, which holds promise in future drug development, in detail. The development of 
efficacious antimycobacterials now requires previously unexplored pathways of the pathogen 
and cofactor biosynthesis pathways present a good starting point. Therefore, the 
mycobacterial Coenzyme A (CoA) biosynthesis was chosen for investigation, with the last 
enzyme of this pathway, dephosphocoenzyme A kinase (CoaE) which was shown to be 
essential for M. tuberculosis survival, as the focus of the present study (Sassetti et al., 2003). 
This thesis presents a detailed biochemical and biophysical characterization of the enzymatic 
mechanism of mycobacterial CoaE, highlighting several hitherto-unknown, unique features 
of the enzyme. Mutagenic studies described herein have helped identify the critical residues 
of the kinase involved in substrate recognition, binding and catalysis. Further, a role has been 
assigned to the UPF0157 domain of unknown function found in the mycobacterial CoaE as 
well as in several organisms throughout the living kingdom. Detailed insights into the 
regulatory characteristics of this enzyme from this work further our current understanding of 
the regulation of the universal CoA biosynthetic pathway and call for the attribution of a 
greater role to the last enzyme in pathway regulation than has been previously accredited.  
 
The thesis begins with a survey of the current literature available on tuberculosis and where 
we stand today in our fight against this dreaded pathogen. Chapter 1 details the 
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characteristic features of the causative organism M. tuberculosis, briefly describing its unique 
genome and the cellular envelope which the organism puts forward as a tough shield to its 
biology. This is followed by a brief description of the infection cycle in the host, the 
pathogen-host interplay in the lung macrophages, the deadly alliance of the disease with HIV 
and our current drug arsenal against tuberculosis. Further, emphasizing on the need for 
newer, faster-acting anti-mycobacterials, Chapter 1 presents the rationale for choosing the 
mycobacterial coenzyme A biosynthetic pathway as an effective target for newer drugs. A 
detailed description of our current understanding of the five steps constituting the pathway 
follows, including a comparison of all the five enzymatic steps between the human host and 
the pathogen. This chapter also sets the objectives of the thesis, describing the choice of the 
last enzyme of the mycobacterial CoA biosynthesis, dephosphocoenzyme A kinase, for 
detailed investigation. As described in Chapter 1, the mycobacterial CoaE is vastly different 
from its human counterpart in terms of its domain organization and regulatory features and is 
therefore a good target for future drug development. 
 
In this thesis, Rv1631, the probable mycobacterial dephosphocoenzyme A kinase annotated 
in the Tuberculist database (http://genolist.pasteur.fr/TubercuList), has been unequivocally 
established as the last enzyme of the tubercular CoA biosynthesis through several 
independent assays detailed in Chapter 2. The gene was cloned from the mycobacterial 
genomic DNA, expressed in E. coli and the corresponding recombinant protein purified via a 
single-step affinity purification method. The mechanistic details of the enzymatic reaction 
phosphorylating dephosphocoenzyme A (DCoA) to the ubiquitous cofactor, Coenzyme A, 
have been described in this chapter which presents a detailed biochemical and biophysical 
characterization of the mycobacterial enzyme, highlighting its novel features as well as 
unknown properties of this class of enzymes belonging to the Nucleoside Tri-Phosphate 
(NTP) hydrolase superfamily. The kinetics of the reaction have been biochemically 
elucidated via four separate assays and the energetics of the enzyme-substrate and enzyme-
product interactions have been detailed by isothermal titration Calorimetry (ITC). Further 
details on the phosphate donor specificity of the kinase and the order of substrate binding to 
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the enzyme provide a complete picture of the enzymatic mechanism of the mycobacterial 
dephosphocoenzyme A kinase. 
 
Following on the leads generated in Chapter 2 on the unexpected strong binding of CTP to 
the enzyme but its inability to serve as a phosphate donor to CoaE, enzymatic assays 
described in Chapter 3 helped in the identification of a hitherto unknown, novel regulator of 
the last enzyme of CoA biosynthesis, the cellular metabolite CTP. This chapter outlines the 
remarkable interplay between the regulator, CTP and the leading substrate, 
dephosphocoenzyme A, possibly employed by the cell to modulate enzymatic activity. The 
interesting twist to the regulatory mechanisms of CoaE added by the involvement of various 
oligomeric forms of the enzyme and the influence of the regulator and the leading substrate 
on the dynamic equilibrium between the trimer and the monomer is further detailed. This re-
equilibration of the oligomeric states of the enzyme effected by the ligands and its role in 
activity regulation is further substantiated by the fact that CoaE oligomerization is not 
cysteine-mediated. Further, the effects of the cellular metabolites on the enzyme have been 
corroborated by limited proteolysis, CD and fluorescence studies which helped elucidate the 
conformational changes effected by CTP and DCoA on the enzyme. Thus, the third chapter 
discusses the novel regulatory features employed by the pathogen to regulate metabolite flow 
through a critical biosynthetic pathway. Results presented in this chapter highlight the fact 
that greater importance should be attributed to the last step of CoA biosynthesis in the overall 
pathway regulation mechanisms than has been previously accorded. 
 
The availability of only three crystal structures for a critical enzyme like 
dephosphocoenzyme A kinase (those from Escherichia. coli, Haemophilus influenzae and 
Thermus thermophilus) is indeed surprising (Obmolova et al., 2001; O’Toole et al., 2003; 
Seto et al., 2005). In search of a structural basis for the dynamic regulatory interplay between 
the leading substrate, DCoA and the regulator, CTP, a computational approach was adopted. 
Interestingly, the mycobacterial enzyme, unlike its other counterparts from the prokaryotic 
kingdom, is a bi-domain protein of which the C-terminal domain has no assigned function. 
Thus both the N- and C-terminal domains were independently modeled, stitched together and 
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energy minimized to generate a three-dimensional picture of the mycobacterial 
dephosphocoenzyme A kinase, as described in Chapter 4.  Ligand-docking analyses and a 
comprehensive analysis of the interactions of each ligand with the enzyme, in terms of the 
residues interacted with and the strength of the interaction, presented in this chapter provide 
interesting insights into the CTP-mediated regulation of CoaE providing a final confirmation 
of the enzymatic inhibition effected by CTP. These homology modeling and ligand-docking 
studies reveal that CTP binds the enzyme at the site overlapping with that occupied by the 
leading substrate, thereby potentially obscuring the active site and preventing catalysis. 
Further, very close structural homology of the modeled full-length enzyme to 
uridylmonophosphate/cytidylmonophosphate kinases, deoxycytidine kinases and cytidylate 
kinases from several different sources, with RMSD values in the range of 2.8-3 Å further 
lend credence to the strong binding of CTP detailed in Chapter 2 and the regulation of 
enzymatic activity described in Chapter 3. Computational analyses on the mycobacterial 
CoaE detailed in this chapter further threw up some interesting features of 
dephosphocoenzyme A kinases, such as the universal DXD motif in these enzymes, which 
appears to play a crucial role in catalysis as has been assessed in the next chapter. 
  
It is interesting to note that the P-loop-containing nucleoside monophosphate kinases 
(NMPK), with which the dephosphocoenzyme A kinases share significant homology, have 
three catalytic domains, the nucleotide-binding domain, the acceptor substrate-binding 
domain and the lid domain. Computational analyses detailed in Chapter 4 including the 
structural and sequential homology studies, helped in the delineation of the three domains in 
the mycobacterial enzyme as well as highly conserved residues potentially involved in 
crucial roles for substrate binding and catalysis. Therefore important residues from all three 
domains of the mycobacterial CoaE were chosen for mutagenesis to study their contributions 
to catalysis. Conservative and non-conservative replacements of these residues detailed in 
Chapter 5 helped in the identification of crucial residues involved in phosphate donor, ATP 
binding (Lys14 and Arg140); leading substrate, DCoA binding (Leu113); stabilization of the 
phosphoryl transfer reaction (Asp32 and Arg140) and catalysis (Asp32). Thus, the results 
reported here present a first attempt to identify the previously unknown functional roles of 
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highly conserved residues in dephosphocoenzyme A kinases. Chapter 5 also delineates the 
dependence of this kinase on the divalent cation, magnesium, for catalysis, describing a 
comparison of the kinetic activity by the wild type and the mutants, in the presence and 
absence of Mg
2+
. Therefore, this chapter presents a thorough molecular dissection of the 
roles played by crucial amino acids of the protein and the results herein can serve as a good 
starting point for targeted drug development approaches. 
 
As described above, another unusual characteristic of the mycobacterial CoaE is the fact that 
it carries a domain of unknown function, UPF0157, C-terminal to the N-terminal 
dephosphocoenzyme A kinase domain. The function of this unique C-terminal domain 
carried by the mycobacterial CoaE has been explored in Chapter 6. The failure of the N-
terminal domain (NTD) to be expressed and purified in the soluble fraction in the absence of 
a domain at its C-terminus (either the mycobacterial CoaE CTD or GST from the 
pETGEXCT vector) pointed out a possible chaperonic activity for the CTD. A universal 
chaperonic activity by this domain in the cell was ruled out by carrying out established 
chaperone assays with insulin, abrin and -crystallin. In order to delineate the CTD sequence 
involved in the NTD-specific chaperoning activity, deletion mutagenesis helped establish the 
residues 35-50 (KIACGHKALRVDHIG) of the CTD in the N-terminal domain-specific 
assistance in folding. Chapter 6 further details the several other potential roles of the 
mycobacterial CTD probed, including the 4’-phosphopantethienyl transfer, SAM-dependent 
methyltransferase activity, activation of the NTD via phospholipids among others. Thus the 
results presented in this chapter are a first attempt at investigating the role of this domain 
found in several unique architectures in several species across the living kingdom. 
 
Chapter 7 is an attempt to stitch together and summarize the results presented in all the 
preceding chapters, giving an overview of our present understanding of the mycobacterial 
CoaE and its novel features. 
  
